Table 2.
Associations between intact PTH after RT and clinical variables.
| Covariates | log intact PTH, ng/mL | Standardized β | P value |
|---|---|---|---|
| Intercept | 5.305 | 0 | <0.0001 |
| Age, year | −0.009 | −0.13 | 0.2821 |
| Duration of dialysis pretransplantation, year | 0.003 | 0.32 | 0.0171 |
| Log intact PTH before RT | 0.274 | 0.24 | 0.0352 |
| Month after RT | −0.003 | −0.09 | 0.3951 |
| eGFR | −0.018 | −0.35 | 0.0082 |
| Adjusted serum Ca | −0.096 | −0.12 | 0.3414 |
| Parathyroidectomy | −0.438 | −0.29 | 0.0169 |
| Medication of calcimimetics | 0.227 | 0.23 | 0.0420 |
The data are the ng/mL associated with each listed covariate, after adjustment for all other covariates listed. The intercept value is added to the covariate value (after appropriate weighting) to obtain the intact PTH estimate. For parathyroidectomy, the intact PTH level in patient who underwent parathyroidectomy compared with patient who did not undergo parathyroidectomy is shown. For medication of calcimimetic, the intact PTH level in patient with medication of calcimimetic compared with patient without medication of calcimimetic is shown. Bold values are those found to be significant; p value <0.05. PTH, parathyroid hormone; RT, renal transplantation; eGFR, estimated glomerular filtration rate.